secwatch / observer
8-K filed August 14, 2023, 7:59 PM ET ticker JOB CIK 0000040570
leadership confidence high sentiment neutral materiality 0.65

GEE Group expands board to nine, adds three directors after Camden resignation

GEE Group Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Carl Camden

Director
JOB · GEE Group Inc.
Effective
2023-08-08
Successor
Jyrl James
Filed
August 14, 2023, 7:59 PM ET
Carl Camden informed the board of directors (the “ Board ”) of the Company that he was resigning from his position as director of the Company effective immediately due to health reasons.
Appointed

Jyrl James

Director
JOB · GEE Group Inc.
Effective
2023-08-11
Filed
August 14, 2023, 7:59 PM ET
On August 11, 2023, the Board appointed Ms. Jyrl James to serve as a member of the Board, effective immediately, to fill the vacancy caused as a result of Mr. Camden’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Carl Camden resigned as Director at GEE Group Inc..

Action
resigned
Role
Director
Exact text from the filing
Carl Camden informed the board of directors (the “ Board ”) of the Company that he was resigning from his position as director of the Company effective immediately due to health reasons.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jyrl James was appointed as Director at GEE Group Inc..

Action
appointed
Role
Director
Exact text from the filing
On August 11, 2023, the Board appointed Ms. Jyrl James to serve as a member of the Board, effective immediately, to fill the vacancy caused as a result of Mr. Camden’s resignation.
View on SEC.gov

GEE Group Inc. filing history →

Source: SEC EDGAR
accession 0001477932-23-006118
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.